Dexilant (dexlansoprazole delayed-release capsules)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  July 2016 ADVERSE REACTIONS Clinical Trials Experience Pediatrics (additional section added) The safety of DEXILANT...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts